The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?

Purpose of reviewPodocyte injury plays a key role in the development of diabetic nephropathy. This review discusses recent advances in our understanding of mechanisms of podocyte injury in diabetes mellitus and the associated alterations in the function of the glomerular filtration barrier. Recent findingsThe effects of hyperglycemia on critical podocyte parameters including cell–cell interactions, attachment to the glomerular basement membrane, and podocyte apoptosis have been determined in both cell culture and in-vivo models of diabetes mellitus. The podocyte has also been identified as a target of action for insulin and growth hormone, hormones with significant roles in the altered homeostasis of diabetes mellitus. SummaryUnderstanding the cellular and molecular basis for changes in podocyte structure and function in diabetes mellitus may lead to novel diagnostic tools and treatment strategies for diabetic nephropathy.

[1]  P. Kimmelstiel,et al.  Intercapillary Lesions in the Glomeruli of the Kidney. , 1936, The American journal of pathology.

[2]  M. Mcilroy,et al.  Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality. , 1980, The Journal of clinical investigation.

[3]  J. Christiansen,et al.  Kidney function and size in normal subjects before and during growth hormone administration for one week , 1981, European journal of clinical investigation.

[4]  S. Zucchini,et al.  Relationships Between Growth Factors (Somatomedin-C and Growth Hormone) and Body Development, Metabolic Control, and Retinal Changes in Children and Adolescents With IDDM , 1986, Diabetes.

[5]  D. Dunger,et al.  Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. , 1990, The Journal of clinical endocrinology and metabolism.

[6]  G. Striker,et al.  Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. , 1990, The American journal of pathology.

[7]  P. Blankestijn,et al.  Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion. , 1993, The Journal of clinical endocrinology and metabolism.

[8]  A. E. El Nahas,et al.  Experimental diabetic renal growth: role of growth hormone and insulin-like growth factor-I. , 1994, Nephrology, Dialysis and Transplantation.

[9]  T. Meyer,et al.  Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.

[10]  J. Kopchick,et al.  Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice. , 1997, Endocrinology.

[11]  M. Lawson,et al.  Contribution of Growth Hormone and IGF-I to Early Diabetic Nephropathy in Type 1 Diabetes , 1998, Diabetes.

[12]  H. Pavenstädt,et al.  Roles of the podocyte in glomerular function. , 2000, American journal of physiology. Renal physiology.

[13]  G. Remuzzi,et al.  Podocyte number in normotensive type 1 diabetic patients with albuminuria. , 2002, Diabetes.

[14]  S. Shankland,et al.  Podocytes that detach in experimental membranous nephropathy are viable. , 2003, Kidney international.

[15]  A. Flyvbjerg,et al.  From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. , 2004, Endocrine reviews.

[16]  J. Gerberding,et al.  Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002. , 2005, MMWR. Morbidity and mortality weekly report.

[17]  G. Wolf,et al.  From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. , 2005, Diabetes.

[18]  J. Tavaré,et al.  The human glomerular podocyte is a novel target for insulin action. , 2005, Diabetes.

[19]  T. Ha.  High glucose and advanced glycosylated end‐products affect the expression of α‐actinin‐4 in glomerular epithelial cells , 2006, Nephrology.

[20]  S. Adler,et al.  Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. , 2006, Kidney international.

[21]  F. Brosius,et al.  Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment , 2006, BMC nephrology.

[22]  S. Shankland,et al.  The podocyte's response to injury: role in proteinuria and glomerulosclerosis. , 2006, Kidney international.

[23]  Ya-ling Bai,et al.  High Ambient Glucose Levels Modulates the Production of MMP-9 and a5(IV) Collagen by Cultured Podocytes , 2006, Cellular Physiology and Biochemistry.

[24]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.

[25]  Hernan Rincon-Choles,et al.  ZO-1 expression and phosphorylation in diabetic nephropathy. , 2006, Diabetes.

[26]  M. Saleem,et al.  Identification of the glomerular podocyte as a target for growth hormone action. , 2007, Endocrinology.

[27]  J. S. Kim,et al.  Activation of the renin-angiotensin system within podocytes in diabetes. , 2007, Kidney international.

[28]  M. Caramori,et al.  Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy , 2007, Diabetes.

[29]  J. Tavaré,et al.  Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes , 2007, Diabetes.